medigraphic.com
Órgano Oficial del Instituto de Ciencias de la Salud, Hospital Escuela y Facultad de Medicina-Xalapa

2007, Número 1

<< Anterior Siguiente >>

Rev Med UV 2007; 7 (1)


Tratamiento farmacológico y trastorno déficit de atención con hiperactividad

Beltrán GFJ, Torres FIA, Vázquez NF, Beltrán TAA, Beltrán GLF

Idioma: Español
Referencias bibliográficas: 50
Paginas: 48-58
Archivo PDF: 311.37 Kb.


RESUMEN

El Trastorno Déficit de Atención con Hiperactividad (TDAH) es un trastorno heterogéneo, lo que implica suponer orígenes diversos. Sin embargo, a pesar de los avances en el conocimiento sobre los factores etiológicos asociados con este trastorno, dicho conocimiento corre el riesgo de no ser interpretado correctamente si no se analiza desde una perspectiva holística, sistémica y del desarrollo. Sin embargo, se le considera en principio una alteración de orden neurológico, lo cual implica una visión médica cuya opción de tratamiento resulta ser el farmacológico. No obstante, los resultados de este tipo de tratamiento están lejos de ser óptimos, debido a lo cual se han probado una multiplicidad de fármacos y dosis en búsqueda de la respuesta farmacológica ideal. Por ello, resulta necesario llevar a cabo investigaciones interdisciplinarias en torno al TDAH, considerando la complejidad de los procesos involucrados en la interacción entre el niño, la familia, el contexto sociocultural y ecológico a lo largo de su desarrollo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Wilens, Timothy E; Spencer, Thomas J. The stimulants revisited. Child & Adolescent Psychiatric Clinics of North America Jul 2000; 9(3): 573-603.

  2. Safer, Daniel J; Zito, Julie M. (1999) Psychotropic medication for ADHD. Mental Retardation & Developmental Disabilities Research Reviews 1999; 5(3): 237-242.

  3. Wentzel, Brian James. Meta-analysis: Differential drug use in attention deficit hyperactivity disorder. Dissertation Abstracts International: Section B: the Sciences & Engineering Dec 2000; 61(5-B).

  4. Brown, Thomas E. Attention-deficit disorders and comorbidities in children, adolescents, and adults. American Psychiatric Press 2000; 509-535.

  5. Gray, Jeremy R; Kagan, Jerome; The challenge of predicting which children with attention deficit-hyperactivity disorder will respond positively to methylphenidate. Journal of Applied Developmental Psychology. Sep-Oct, 2000; 21(5):71-489.

  6. Berman, Tamara; Effects of methylphenidate on complex cognitive processing in Attention-Deficit Hyperactivity Disorder. Dissertation Abstracts International: Section B: the Sciences & Engineering., 3270, US: Univ Microfilms International. Jan, 2000; 61(6-B).

  7. Oeztuerk, Muecahit; Sayar, Kemal; Tuezuen, Uemran; Kandil, Sema Tanrioever Methylphenidate and self-esteem in Attention Deficit Hyperactivity Disorder. Klinik Psikofarmakoloji Buelteni 2000; 10(3): 139-143.

  8. Arnold-von Saher, R. A; Boer, F; Burggraaf, J. The clinical use of a double-blind placebocontrolled trial with methylphenidate: Advantages and limitations. Tijdschrift voor Psychiatrie 2000; 42(11): 837-844.

  9. Singh, Ilina A crutch, a tool: How mothers and fathers of boys with ADHD experience and understand the work of ritalin. Dissertation Abstracts International: Section B: the Sciences & Engineering. 1114, US: Univ Microfilms International Aug 2000; 61: (2-B).

  10. Pozzi, Maria E. Ritalin for whom? Understanding the need for Ritalin in psychodynamic counselling with families of under-5s. Journal of Child Psychotherapy Apr 2000; 26(1): 25-43.

  11. Ardoin, Scott P; Martens, Brian K. Testing the ability of children with attention deficit hyperactivity disorder to accurately report the effects of medication on their behavior. Journal of Applied Behavior Analysis 2000; 33(4): Win, 593-610.

  12. Vyse Stuart A, Rapport Mark D. The effects of methylphenidate on learning in children with DATH: The stimulus equivalence paradigm. Journal of Consulting & Clinical Psychology Jun 1989; 57(3): 425-435.

  13. Tannock Rosemary, Schachar Russell, Logan, Gordon D. Does methylphenidate induce overfocusing in hyperactive children Journal of clinical Child Psychology Mar 1993; 22(1): 28-42.

  14. Murphy, Debra A,Pelham, William E. Lang, Alan R. Aggression in boys with attention deficithyperactivity disorder: Methylphenidate effects on naturalistically observed aggression, response to rovocation, and social information processing. Journal of Abnormal Child Psychology Oct 1992;20(5): 451-466.

  15. Hinshaw Stephen P, Henker Barbara, Whalen Carol K, Erhardt, Drew Aggressive, prosocial and nonsocial behaviour in hyperactive boys: Dose effects of methylphenidate in naturalistic settings Oct 1989; 57(5): 636-643.

  16. Alston Cheryl Y; Romney David M. A comparison of medicated and nonmedicated attentiondeficit disordered hyperactive boys. Acta Paedopsychiatrica: Internacional. Journal of child & adolescent Psychiatry 1992; 55(2): 65-70.

  17. Carlson, Caryn L, Pelham, William E, Swanson, James M, Wagner, Jana L. Adivided attention analysis of the effects of methylphenidate on the arithmetic performance of children with Attention- Deficit Hyperactivity Disorder. Journal of Child Psychology & Psychiatry & Allied Disciplines Mar 1991; 32(3): 463-471.

  18. Ajibola Olatunji y Clement Paul W. Differential effects of methyphenidate and self-reinforcement on attention-deficit hyperactivity disorder. Behaviour Modification Apr 1995; 19(2): 211-233.

  19. Tannock Rosemay, Ickowicz Abel, Schachar Rusell. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. Journal of the American Academy of Child & Adolescent Psychiatry Jul 1995 34(7): 886-896.

  20. Handen Benjamin L, Breaux, Anna M, Janosky, Janine, Mc Auliffe, Sarah. Effects and noneffects on methylphenidate in children with mental retardation and ADHD. Journal of the American Academy of child & Adolescent Psychiatry May 1992; 31(3): 455-461.

  21. Gadow, Kenneth D. Nolan, Edith E. Paolicelli, Lucia M Sprafkin, Joyce. A procedure for assessing the effects of methylphenidate on hyperactive children in public school settings, Special Issue: Child psychopharmacology. Journal of Clinical Child Psychology Sep 1991; 20(3): 268-276.

  22. Gadow, Kenneth D, Pomeroy, John C, Nolan, Edith E. Aprocedure for monitoring stimulant medication in hyperactive mentally retarded school children. Journal of Child & Adolescent Psychopharmacology 1992; 2(2): 131-143

  23. Horn, Wade F, Ialongo, Nicholas S, Pascoe, John M, Greenberg, Gregory “Additive effects of psychostimulants, parent training, and selfcontrol therapy with ADHD children. Journal of the American Academy of Child & Adolescent Psychiatr Mar 1991; 30(2): 233-240.

  24. Hoza Betsy, Pelham, William E, Sams, Susan E, Carlson, Caryn. An examination of the “dosage” effects of both behaviour therapy and methylphenidate on the classroom performance of two (ADHD). Behavior Modification Apr 1992; 16(2): 164-192.

  25. Gomez Karen M, Cole Christine L. Attention deficit hyperactivity disorder: A review of treatment alternatives. Elementary School Guidance & Counseling Dec 1991; 26(2):106-114.

  26. Klein R.G. Clinical efficacy of methylphenidate in children and adolescents. Encephale Mar-Apr 1993 18(2): 89-93.

  27. Carlson, Caryn. ADHD boys’ performance and attributions following success and failure: Drug effects and individual differences. Cognitive Therapy& Research Jun 1993; 17(3): 269-287.

  28. Fine, Stuart y Johnston, Charlotte. Drug and placebo side effects in methyphenidate-placebo trial for attention deficit hyperactivity disorder. Child Psychiatry & Human Development 1993; 22 (2): Win, 79-87.

  29. Cooper Linda J, Wacker, David P, Millard, Thomas, Derby K, Mark. Assessing environmental and medication variables in an outpatient setting: A proposed model and preliminary results with ADHD children. Special Issue: Pharmacotherapy. Journal of Developmental & Physical Disabilities Mar 1993; 5 (1):71-85.

  30. Fischer, Mariellen, Newby, Robert F. Assessment of stimulant response in ADHD children using a refined multimethod clinical protocol. Special Issue: Child psychopharmacology. Journal of Clinical Child Psychology Sep 1991; 20(3): 232-244.

  31. Rapport Mark D, Quinn, Sheila O, Dupaul, George J Quinn, Eugene P. Attention deficit disorder with hyperactivity and methylphenidate: The effects of dose and mastery level on children are learning performance. Journal of Abnormal Child Psychology Dec 1989; 17(6): 669-689.

  32. Rapport Mark D, Denney, Colin. DuPaul, George J George J Gardner, Mark J. Attention deficit disorder and methylphenidate: Normalization rates, clinical effectiveness, and response prediction in 76 children. Journal of the American Academy of Child & Adolescent Psychiatry Jul-Aug. 1994; 33(6): 882-893.

  33. Milich, Richard, Licht, Barbara G, Murphy, Debra A, Pelham William E. Attention-deficit hyperactivity disordered boys, evaluations of and attributions for task performance on medication versus placebo. Journal of Abnormal Psychology Aug 1989; 98(3): 280-284.

  34. Biederman, Joseph, Baldessarini, Ross J. Wright, Virginia, Keenan, Kate Adouble-blind placebo controlled study of desipramina in the treatment of ADD: III. Lack of comorbidity and family history factors on clinical response. Journal of the American Academy of Child & Adolescent Psychiatr Jan 1993; 32(1): 199-204.

  35. Biederman, Joseph, Milberger, Sharon, Faraone, Stephen V, Guite, Jessica. Associations between childhood asthma and ADHD: Issues of psychiatric comorbidity and familiality. Journal of the American Academy of Child & Adolescent Psychiatry Jul-Aug. 1994; 33(6): 842-848.

  36. Varley, Christopher K. Sudden death of a child treated with Imipramine. Journal of Child & Adolescent Psychopharmacology 2000; 10(4): Win, 321-325.

  37. Taylor, Fletcher B; Russo, Joan. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. Journal of Child & Adolescent Psychopharmacology 2000; 10(4): Win, 311-320.

  38. Faraone, Stephen V; Biederman, Joseph; Spencer, Thomas J; Wilens, Timothy E. The drug-placebo response curve: A new method for assessing drug effects in clinical trials. Journal of Clinical Psychopharmacology Dec 2000; 20(6): 673-679.

  39. Lore, Cathy. Risperidone and withdrawal dyskinesia. Journal of the American Academy of Child & Adolescent Psychiatry Aug 2000; 39(8):941.

  40. Barkley, Russell A; Connor, Daniel F; Kwasnik, Denise.Challenges to determining adolescent medication response in an outpatient clinical setting: Comparing Adderall and methylphenidate for ADHD. Journal of Attention Disorders Aug 2000; 4(2):102-113.

  41. Comings David E, Comings, Brenda G, Tacket, Tracy, Li, Suzi .The clonidina patch and behaviour problems. Journal of the American Academy of Child & Adolescent Psychiatry Jul 1990; 29(4):667-668.

  42. Friedman, Debra L, Kastner, Ted Plummer, Alice T, Ruiz, Marilyn Q. Adverse behavioural effects in individuals with mental retardation and mood disorders treated with carbamazepina. American Journal on Mental Retardation Mar 1992; 96(5):541-546.

  43. Mc Gee Rob, Stanton, Warren R, Sears, Malcolm R. Allergic disorders and attention deficit disorder in children. Journal of Anormal child Psychology Feb 1993; 21(1): 79-88.

  44. Pelham, William E. Jr; Gnagy, Elizabeth M; Greiner, Andrew R; Hoza, Betsy; Hinshaw, Stephen P; Swanson, James M; Simpson, Steve; Shapiro, Cheri; Bukstein, Oscar; Baron-Myak, Carrie; McBurnett, Keith. Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. Journal of Abnormal Child Psychology Dec 2000; 28(6): 507-525.

  45. Murray, Laura K; Kollins, Scott H. Effects of methylphenidate on sensitivity to reinforcement in children diagnosed with attention deficit hyperactivity disorder: An application of the matching law. Journal of Applied Behavior Analysis. Society for the Experimental Analysis of Behavior Inc, US 2000; 33(4): Win 573-591.

  46. Lieberman, Susan Cornelia. The effect of an afternoon dose of methylphenidate on the on-task, accuracy and productivity of the homework completed by children with attention deficit hyperactivity disorder. Dissertation Abstracts International: Section B: the Sciences & Engineering Mar 2000; 60(8-B)

  47. Connor, Daniel F; Barkley, Russell A; Davis, Heather T. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clinical Pediatrics Jan 2000; 39(1):15

  48. Popper, Charles W. Pharmacologic alternatives to psychostimulants for the treatment of attentiondeficit/ hyperactivity disorder. Child & Adolescent Psychiatric Clinics of North America Jul 2000; 9(3): 605-646.




2020     |     www.medigraphic.com